Interindividual Transcriptional Regulation of the Human biglycan Gene Involves Three Common Molecular Haplotypes
Author(s) -
Boris Schmitz,
Andrea Salomon,
Alois Rötrige,
Martin Ritter,
E B Ringelstein,
Jens W. Fischer,
Martin Paul,
Eva Brand,
StefanMartin Brand
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.112.301073
Subject(s) - biglycan , chromatin immunoprecipitation , promoter , biology , microbiology and biotechnology , genetics , gene , transcriptional regulation , electrophoretic mobility shift assay , transcription factor , gene expression , proteoglycan , decorin , extracellular matrix
The extracellular matrix proteoglycan biglycan (BGN) is involved in cardiovascular disease pathophysiology, as it mediates the subendothelial retention of atherogenic apolipoprotein B-containing lipoproteins, affects adaptive remodeling after myocardial infarction, and exerts proinflammatory effects in macrophages. In a cardiovascular disease-related setting of vascular endothelial cells and human monocytes, we examined the molecular mechanisms of common molecular haplotypes affecting human BGN transcriptional regulation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom